References
- Alm A, Grierson I, Shields MB. Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 2008;53(suppl 1):S93–S105.
- Chiba T, Kashiwagi K, Chiba N, Ishijima K, Furuichi M, Kogure S, et al. Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long-term prospective comparative study. Br J Ophthalmol 2003;87:956–9.
- Parrish RK, Palmberg P, Sheu WP. A comparison of latanoprost, bimotoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688–703.
- Doshi M, Edward DP, Osmanovic S. Clinical course of bimatoprost-induced periocular skin changes in Caucasians. Ophthalmology 2006;113:1961–7.
- Wand M, Ritch R, Isbey EK Jr, Zimmerman, TJ. Latanoprost and periocular skin color changes. Arch Ophthalmol 2001;119:614–5.
- Herndon LW, Robert DW, Wand M, Asrani S. Incre ased periocular pigmentation with ocular hypotensive lipid use in African Americans. Am J Ophthalmol 2003;135:713–5.
- Kook MS, Lee K. Increased eyelid pigmentation associated with use of latanoprost. Am J Ophthalmol 2000;129:804–6.
- Kapur R, Osmanovic S, Toyran S, Edward DP. Bimatoprost-induced periocular skin hyperpigmentation: histopathological study. Arch Ophthalmol 2005;123:1541–6.